SCT

PROCEDURE3 trials

Conditions

Acute Lymphoblastic LeukemiaAcute Myelogenous LeukemiaCritical Limb IschemiaGraft Vs Host DiseaseIrradiated Bone MarrowLeukemia, AcuteLymphomaMultiple Myeloma

Phase 1

Safety Study of Gene Modified Donor T-cells Following Partially Mismatched Stem Cell Transplant

Active, not recruitingNCT01744223

Bellicum PharmaceuticalsAcute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Lymphoma +1

Start: 2013-03-31End: 2032-10-31Target: 36Updated: 2022-07-12

Treosulfan-TMI Conditioning and Rapamycin GvHD Prophylaxis Before Allo-HSCT

TerminatedNCT03963024

IRCCS San RaffaeleGraft Vs Host Disease, Irradiated Bone Marrow, Leukemia, Acute +2

Start: 2014-02-12End: 2019-01-31Updated: 2020-10-19

Unknown Phase

Study of the Clinical Efficacy of Autologous SCT in Patients With Critical Limb Ischemia

NCT01311011

King Faisal Specialist Hospital & Research CenterCritical Limb Ischemia

Start: 2008-11-30Target: 26Updated: 2011-12-13

Related Papers

Cellular Immunotherapies for Leukemia Patients

Oncology Times2017-01-10

BPX-501 Cells (Donor T Cells Transduced with iC9 Suicide Gene) Treatment Following TCR Alpha Beta Depleted Stem Cell Transplantation in Adults and Children with Hematological Disorders

Biology of Blood and Marrow Transplantation2016-02-18

SCT

Sponsors

Conditions

Phase 1

Unknown Phase

Related Papers